Basic Information
- ▪JIA is a chronic autoimmune condition affecting the joints and eyes
- ▪By definition, age of onset is <16 years, and symptoms of arthritis must be present for at least 6 weeks
- ▪Untreated arthritis leads to joint contractures and permanent joint damage
- ▪Untreated uveitis (eye inflammation) leads to blindness
- ▪There are six subtypes with varying prognosis and clinical manifestations:
- ▪Oligoarticular JIA
- ▪Polyarticular JIA with negative rheumatoid factor (RF)
- ▪Polyarticular JIA with positive RF
- ▪Psoriatic JIA
- ▪Enthesitis-related JIA
- ▪Systemic-onset JIA
Clinical Presentation
- ▪In all subtypes, stiffness and joint swelling are more prominent than joint pain
- ▪Decreased range of motion progresses over time
- ▪Leg length discrepancies or even growth retardation can result from chronic lower-extremity arthritis
- ▪Micrognathia and jaw asymmetry can result from temporomandibular joint arthritis
Oligoarticular JIA
▪
Most commonly occurs in toddler-age (3 years old) Caucasian females
▪
Four or more joints are involved initially
▪
Large joints, knee > ankle > wrist (but almost never hip or shoulder)
▪
Insidious onset
▪
Frequently antinuclear antibody (ANA) positive → highest risk of uveitis
▪
Uveitis is usually asymptomatic; therefore all patients require regular ophthalmologic screening
Polyarticular JIA
▪
Bimodal peak at age 1 to 3 years, and then adolescence, with female predominance
▪
More than five joints are involved
▪
Symmetrically involves small joints of hands and feet, in addition to large joints
▪
RF positivity confers a worse prognosis:
▪
Similar to adult rheumatoid arthritis; subcutaneous rheumatoid nodules may be present
▪
Asymptomatic uveitis is less common than in oligoarticular JIA
Psoriatic JIA
▪
Arthritis and psoriasis or other features that overlap with psoriasis:
▪
Dactylitis (“sausage digits”), nail pits or onycholysis, family history of psoriasis
▪
Asymmetrically involves small joints (especially distal interphalangeal [DIP]) and large joints
▪
Asymptomatic uveitis (especially if ANA positive)
Enthesitis-related JIA/juvenile ankylosing spondylitis
- ▪Frequently HLA-B27 positive, and more common in adolescent boys
- ▪Family history of other HLA-B27-positive spondyloarthropathies (ankylosing spondylitis, sacroiliitis with inflammatory bowel disease, reactive arthritis)
- ▪Peripheral arthritis, enthesitis, or axial involvement:
- ▪Inflammatory back pain is associated with sacroiliitis
- ▪Back stiffness that is worse in the morning or with prolonged sitting and that improves with activity
- □Difficulty with forward flexion and flattening of the natural lumbar lordosis
- □Tenderness over the sacroiliac joints
- ▪Back stiffness that is worse in the morning or with prolonged sitting and that improves with activity
- ▪Enthesitis is tenderness at insertion sites of tendons/ligaments into bone
- ▪Enthesitis-related JIA can progress to ankylosing spondylitis in adult years (fusion of lumbar vertebrae results in the classic “bamboo spine” radiographic finding)
- ▪Inflammatory back pain is associated with sacroiliitis
- ▪Uveitis presents as an acute, painful red eye rather than asymptomatic uveitis
- ▪Significant overlap with inflammatory bowel disease–associated arthropathies, so close monitoring for gastrointestinal symptoms is necessary
Systemic-onset JIA
▪
Previously known as Still disease, it is a completely separate disease from other JIA subtypes
▪
Characterized by severe autoinflammation with peak onset at 1 to 5 years old:
▪
High-spiking fevers for at least 2 weeks, classically in a quotidian (daily) pattern
▪
Evanescent salmon-colored macules appear in conjunction with fever
▪
May appear in linear streaks or look urticarial with surrounding pallor
▪
Lymphadenopathy and hepatosplenomegaly
▪
Serositis (pleural/pericardial effusions, ascites)
▪
Polyarticular arthritis (especially hip and cervical spine)
▪
Not associated with a risk of uveitis
▪
Frequently complicated by macrophage activation syndrome (MAS), also known as secondary hemophagocytic lymphohistiocytosis, which is a severe, life-threatening state of dysregulated systemic inflammation and organ failure
Diagnosis and Evaluation
▪
Laboratory testing can help characterize the type of JIA but is not used to make a diagnosis of JIA:
▪
ANA determines risk of uveitis
▪
A positive ANA at low titers (1:160) can be detected in up to 20% of healthy children, and therefore it is not useful for diagnosis
▪
RF and HLA-B27 help determine JIA subtype
▪
Lyme should be excluded as a cause of chronic arthritis
▪
A mild leukocytosis, thrombocytosis, normocytic anemia, and mildly elevated ESR/CRP may be associated with active oligoarticular or polyarticular JIA
▪
In contrast, systemic-onset JIA is characterized by prominent leukocytosis, thrombocytosis, anemia, and elevated acute-phase reactants, especially ferritin
▪
± Transaminitis, hypoalbuminemia, prolonged coagulation time
▪
Cytopenias and dropping ESR (from fibrinogen consumption) in the setting of rising ferritin levels are indicators of MAS
▪
Synovial fluid analysis confirms that the effusion is inflammatory (WBC 5,000–20,000; up to 100,000 in systemic-onset JIA)
▪
Ultrasound can be used to demonstrate joint effusions if clinical examination is equivocal
▪
Demonstration of uveitis on slit-lamp examination can substantiate the diagnosis
Treatment
▪
All children suspected of having JIA should be referred to a rheumatologist
▪
Those diagnosed with JIA require ophthalmologic screening at regular intervals
▪
Mono- or oligoarticular arthritis is usually amenable to intraarticular corticosteroid injections
▪
Immunosuppressants such as low-dose methotrexate are usually needed for polyarticular arthritis
▪
NSAIDs can be helpful for pain and very mild arthritis
▪
Systemic-onset JIA is treated with systemic corticosteroids in combination with other antiinflammatory medications